Next Science Statistics
Total Valuation
Next Science has a market cap or net worth of 28.64 million. The enterprise value is 33.02 million.
| Market Cap | 28.64M |
| Enterprise Value | 33.02M |
Important Dates
The next estimated earnings date is Sunday, October 26, 2025.
| Earnings Date | Oct 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 292.63M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +7.19% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 139.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.30 |
| PB Ratio | -51.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.50 |
| EV / Sales | 1.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.75 |
Financial Position
The company has a current ratio of 1.38
| Current Ratio | 1.38 |
| Quick Ratio | 1.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.92 |
| Interest Coverage | -12.63 |
Financial Efficiency
Return on equity (ROE) is -289.70% and return on invested capital (ROIC) is -85.88%.
| Return on Equity (ROE) | -289.70% |
| Return on Assets (ROA) | -50.99% |
| Return on Invested Capital (ROIC) | -85.88% |
| Return on Capital Employed (ROCE) | -187.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 2.07 |
| Inventory Turnover | 5.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.79% in the last 52 weeks. The beta is 1.13, so Next Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -59.79% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 29.57 |
| Average Volume (20 Days) | 1,426 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Next Science had revenue of 22.07 million and -9.43 million in losses. Loss per share was -0.03.
| Revenue | 22.07M |
| Gross Profit | 18.20M |
| Operating Income | -8.68M |
| Pretax Income | -9.43M |
| Net Income | -9.43M |
| EBITDA | -8.22M |
| EBIT | -8.68M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 971,237 in cash and 5.30 million in debt, giving a net cash position of -4.33 million.
| Cash & Cash Equivalents | 971,237 |
| Total Debt | 5.30M |
| Net Cash | -4.33M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -557,034 |
| Book Value Per Share | -0.00 |
| Working Capital | 1.82M |
Cash Flow
In the last 12 months, operating cash flow was -5.71 million and capital expenditures -34,675, giving a free cash flow of -5.74 million.
| Operating Cash Flow | -5.71M |
| Capital Expenditures | -34,675 |
| Free Cash Flow | -5.74M |
| FCF Per Share | n/a |
Margins
Gross margin is 82.48%, with operating and profit margins of -39.35% and -42.74%.
| Gross Margin | 82.48% |
| Operating Margin | -39.35% |
| Pretax Margin | -42.74% |
| Profit Margin | -42.74% |
| EBITDA Margin | -37.24% |
| EBIT Margin | -39.35% |
| FCF Margin | n/a |
Dividends & Yields
Next Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.19% |
| Shareholder Yield | n/a |
| Earnings Yield | -32.93% |
| FCF Yield | -20.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Next Science has an Altman Z-Score of -12.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.66 |
| Piotroski F-Score | 3 |